Amphastar Pharmaceuticals, Inc. (AMPH) vs OPKO Health, Inc. (OPK)

A side-by-side comparison of Amphastar Pharmaceuticals, Inc. and OPKO Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — AMPH vs OPK

growth of $100 · dividends reinvested · last 10y
AMPH +32.8% (+2.9%/yr)OPK -85.2% (-17.4%/yr)AMPH compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $10020182020202220242026$133$15
AMPH OPK

AMPH vs OPK: by the numbers

  • •AMPH is the larger company ($1.13B vs $1.12B market cap).
  • •AMPH is profitable (10.76% net margin) while OPK runs a net loss (-12.40%).
  • •AMPH grew revenue faster over the past five years (13.71% vs -21.00% CAGR).

Metrics side by side

Valuation

MetricAMPHOPK
P/E ratio15.16N/A
Forward P/E8.62N/A
PEG ratio0.11N/A
P/S ratio1.551.90
P/B ratio1.470.95
EV / EBITDA8.88N/A
FCF yield13.54%N/A

Profitability

MetricAMPHOPK
Gross margin47.68%21.10%
Operating margin15.66%-36.08%
Net margin10.76%-12.40%
ROE10.23%-6.16%
ROIC5.93%-8.86%

Growth (annualized)

MetricAMPHOPK
Revenue CAGR (5Y)13.71%-21.00%
EPS CAGR (5Y)134.23%N/A
FCF CAGR (5Y)23.90%N/A
Total return CAGR (5Y)6.13%-15.39%

Frequently asked

Which has grown faster, AMPH or OPK?
Over the past five years, AMPH grew revenue faster — AMPH at a 13.71% CAGR versus OPK at -21.00%.
Is AMPH or OPK more profitable?
AMPH runs the higher net margin — AMPH at 10.76% versus OPK at -12.40%.
How have AMPH and OPK total returns compared?
Over the past 10 years, AMPH delivered 2.47% and OPK delivered -17.50% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.